Members of the Drew Lab and CTEU Biobank Staff

Drew Headshot.png


Principal Investigator / Director of Biobanking

Dr. Drew is an Instructor of Medicine at Harvard Medical School and Instructor of Investigation with the Clinical & Translational Epidemiology Unit (CTEU) and Division of Gastroenterology at Massachusetts General Hospital. His specific research interests are in the identification, interception and precision prevention of gastrointestinal cancers and other diseases. He has a specialized expertise in clinical trial design and implementation, especially with respect to studies of the gut microbiome and precision risk biomarkers. His research is highly collaborative and achievements have been nationally and internationally recognized by professional organizations, including the American Association for Cancer Research, the American Gastroenterological Association, and Aspirin for Cancer Prevention/European Hereditary Tumor Group. He is funded by the NIH/NIDDK (K01DK120742), the American Gastroenterological Association, and is an NIH Loan Repayment Ambassador through the NCI (L30CA209764). He has received past funding from the MGH Center for the Study of Inflammatory Bowel Disease (CSIBD) and a Cancer Epidemiology Training grant (T32CA009001). Dr. Drew received a B.S. in Biochemistry/Biophysics from Rensselaer Polytechnic Institute (2009) and a Ph.D. in Biomedical Science from UConn Health (2014; Mentor, Daniel W. Rosenberg, PhD)

In addition to his research activities, as Director of Biobanking for the CTEU, Dr. Drew manages the clinical trials portfolio and biobanking efforts of the CTEU. He oversees a team consisting of a project manager, clinical research coordinators and laboratory technicians to shepherd other investigators through protocol development, IRB approval, clinical implementation, laboratory/biobanking procedures, and regulatory compliance.